BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 7581726)

  • 1. Effect of intravenous gammaglobulin (IVIG) on the platelet count in patients with Wiskott-Aldrich syndrome.
    Mathew P; Conley ME
    Pediatr Allergy Immunol; 1995 May; 6(2):91-4. PubMed ID: 7581726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous immunoglobulin, splenectomy, and antibiotic prophylaxis in Wiskott-Aldrich syndrome.
    Litzman J; Jones A; Hann I; Chapel H; Strobel S; Morgan G
    Arch Dis Child; 1996 Nov; 75(5):436-9. PubMed ID: 8957959
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lentiviral haemopoietic stem/progenitor cell gene therapy for treatment of Wiskott-Aldrich syndrome: interim results of a non-randomised, open-label, phase 1/2 clinical study.
    Ferrua F; Cicalese MP; Galimberti S; Giannelli S; Dionisio F; Barzaghi F; Migliavacca M; Bernardo ME; Calbi V; Assanelli AA; Facchini M; Fossati C; Albertazzi E; Scaramuzza S; Brigida I; Scala S; Basso-Ricci L; Pajno R; Casiraghi M; Canarutto D; Salerio FA; Albert MH; Bartoli A; Wolf HM; Fiori R; Silvani P; Gattillo S; Villa A; Biasco L; Dott C; Culme-Seymour EJ; van Rossem K; Atkinson G; Valsecchi MG; Roncarolo MG; Ciceri F; Naldini L; Aiuti A
    Lancet Haematol; 2019 May; 6(5):e239-e253. PubMed ID: 30981783
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of different intravenous immunoglobulin regimens on hemorrhages, platelet numbers and volume in a child with Wiskott-Aldrich syndrome.
    de Martino M; Galli L; Azzari C; Zammarchi E; Vierucci A
    Vox Sang; 1994; 67(3):317-9. PubMed ID: 7863634
    [No Abstract]   [Full Text] [Related]  

  • 5. Randomized trial of high-dose methylprednisolone versus intravenous immunoglobulin for the treatment of acute idiopathic thrombocytopenic purpura in children.
    Ancona KG; Parker RI; Atlas MP; Prakash D
    J Pediatr Hematol Oncol; 2002 Oct; 24(7):540-4. PubMed ID: 12368690
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of severe thrombocytopenia with IL-11 in children with Wiskott-Aldrich syndrome.
    Braithwaite K; Abu-Ghosh A; Anderson L; Cairo MS
    J Pediatr Hematol Oncol; 2002 May; 24(4):323-6. PubMed ID: 11972106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kawasaki disease in a patient with Wiskott-Aldrich syndrome: an increase in the platelet count.
    Kawakami C; Miyake M; Tamai H
    Int J Hematol; 2003 Feb; 77(2):199-200. PubMed ID: 12627860
    [No Abstract]   [Full Text] [Related]  

  • 8. A comparative study of initial use of intravenous immunoglobulin and prednisolone treatments in childhood idiopathic thrombocytopenic purpur.
    Ou CY; Hsieh KS; Chiou YH; Chang YH; Ger LP
    Acta Paediatr Taiwan; 2006; 47(5):226-31. PubMed ID: 17352309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A randomized and comparative study of intravenous immunoglobulin and mega dose methylprednisolone treatments in children with acute idiopathic thrombocytopenic purpura.
    Erduran E; Aslan Y; Gedik Y; Orhan F
    Turk J Pediatr; 2003; 45(4):295-300. PubMed ID: 14768792
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A multiinstitutional survey of the Wiskott-Aldrich syndrome.
    Sullivan KE; Mullen CA; Blaese RM; Winkelstein JA
    J Pediatr; 1994 Dec; 125(6 Pt 1):876-85. PubMed ID: 7996359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lentiviral gene therapy corrects platelet phenotype and function in patients with Wiskott-Aldrich syndrome.
    Sereni L; Castiello MC; Di Silvestre D; Della Valle P; Brombin C; Ferrua F; Cicalese MP; Pozzi L; Migliavacca M; Bernardo ME; Pignata C; Farah R; Notarangelo LD; Marcus N; Cattaneo L; Spinelli M; Giannelli S; Bosticardo M; van Rossem K; D'Angelo A; Aiuti A; Mauri P; Villa A
    J Allergy Clin Immunol; 2019 Sep; 144(3):825-838. PubMed ID: 30926529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dose versus high-dose immunoglobulin for primary treatment of acute immune thrombocytopenic purpura in children: results of a prospective, randomized single-center trial.
    Benesch M; Kerbl R; Lackner H; Berghold A; Schwinger W; Triebl-Roth K; Urban C
    J Pediatr Hematol Oncol; 2003 Oct; 25(10):797-800. PubMed ID: 14528103
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prophylactic platelet transfusion in children with thrombocytopenic disorders: a retrospective review.
    Ferrara M; Capozzi L; Coppola A; Save G; Coppola L
    Hematology; 2007 Aug; 12(4):297-9. PubMed ID: 17654055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Splenectomy in the management of the thrombocytopenia of the Wiskott-Aldrich syndrome.
    Lum LG; Tubergen DG; Corash L; Blaese RM
    N Engl J Med; 1980 Apr; 302(16):892-6. PubMed ID: 6767187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical features and genotype analysis of 132 patients with Wiskott-Aldrich syndrome].
    Li W; Liu D; Zhang X; Ding Y; Zhao X
    Zhonghua Er Ke Za Zhi; 2015 Dec; 53(12):925-30. PubMed ID: 26887548
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Descending aortic aneurysm in Wiskott-Aldrich syndrome: options for repair.
    Wood G; Booth K; Khan Z; Biss T; Roysam C; Dark J
    Asian Cardiovasc Thorac Ann; 2017 Nov; 25(9):635-637. PubMed ID: 29022827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and Safety of Anti-D Immunoglobulins versus Intravenous Immunoglobulins for Immune Thrombocytopenia in Children: Systematic Review and Meta-analysis of Randomized Controlled Trials.
    Lioger B; Maillot F; Ternant D; Passot C; Paintaud G; Bejan-Angoulvant T
    J Pediatr; 2019 Jan; 204():225-233.e8. PubMed ID: 30314658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autonomous role of Wiskott-Aldrich syndrome platelet deficiency in inducing autoimmunity and inflammation.
    Sereni L; Castiello MC; Marangoni F; Anselmo A; di Silvestre D; Motta S; Draghici E; Mantero S; Thrasher AJ; Giliani S; Aiuti A; Mauri P; Notarangelo LD; Bosticardo M; Villa A
    J Allergy Clin Immunol; 2018 Oct; 142(4):1272-1284. PubMed ID: 29421274
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized trial of anti-D immunoglobulin versus low-dose intravenous immunoglobulin in the treatment of childhood chronic idiopathic thrombocytopenic purpura.
    El Alfy MS; Mokhtar GM; El-Laboudy MA; Khalifa AS
    Acta Haematol; 2006; 115(1-2):46-52. PubMed ID: 16424649
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Effects of maintenance treatment after high-dose intravenous gamma-globulin for idiopathic thrombocytopenic purpura].
    Yasunaga K; Kokawa T; Fujitake H; Nomura S; Kageyama T; Ohyabu H; Tatsumi N; Im T; Park K; Kawagoe H
    Rinsho Ketsueki; 1991 Sep; 32(9):938-44. PubMed ID: 1719256
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.